samedan logo
 
 
 
spacer
home > pmps > Autumn 2020
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Autumn 2020

   
Text
PDF
bullet
Formulations, Ingredients and Excipients
Formulations, Ingredients and Excipients

Accelerating Nanotherapeutics

Nanotherapeutics are currently worth $24 billion. The sector is set to grow exponentially over the next decade as targeted medical treatments become more of a necessity.
 
view
download pdf
bullet
Cleanrooms and Sterilisation
Cleanrooms and Sterilisation

Cleanroom Thermoforming – Future-Proofing Medical Devices

Consistency, clarity, and improved ergonomics make thermoformed packaging invaluable for nurses. How can thermoforming help to protect medical devices and secure products for longer?
 
view
download pdf
bullet
Cold Chain Challenges
Cold Chain Challenges

Warming Up to Frozen Distribution

With around 150 vaccines in development globally, the solution to COVID-19 may be around the corner. How it is distributed around the world, however, will soon become the question that the pharmaceutical industry must answer.
 
view
download pdf
Cold Chain Challenges

Rapid Vaccine Distribution to Over 7.5 Billion Humans

The safe distribution of a COVID-19 vaccine will likely utilise cold chain services; yet plenty of environmental and economical concerns remain about their use for the mammoth task of supplying billions with a vaccine.
 
view
download pdf
Cold Chain Challenges

Is There a Future in Biothermal Packaging?

From the challenges around rest materials to the opportunities for the industry, Temax explores the difference that biothermal packaging can make both environmentally and logistically.
 
view
download pdf
Cold Chain Challenges

How to Prepare a GDP Inspection: Lessons Learned

COVID-19 has forced many changes in the industry. Some things, such as Good Distribution Practices (GDP), must continue to monitor and track the supply chain at this vital time.
 
view
download pdf
Cold Chain Challenges

The Vital Role of Cold Chain Technology

The impending headache caused by distributing a sub-zero vaccine around the world without any issues is certain to challenge the industry. How can cold chain technology make a difference at this crucial time?
 
view
download pdf
Cold Chain Challenges

The Decline of Cold Chain

As more and more companies try to reduce the environmental impact of their supply chain solutions, cold chain faces an uphill battle to adapt amid the growing sustainability concerns.
 
view
download pdf
Cold Chain Challenges

Converging Refrigeration Technologies Solutions to Environmental Legislation
 
 
The EU’s F-gas legislation has challenged pharmaceutical businesses to reverse their use of hydrofluorocarbons (HFCs) in refrigeration. Technology may offer alternatives, but they come at a price.
 
view
download pdf
bullet
Improving Patient Adherence
Improving Patient Adherence

Battling ‘Operating Error’

Design flaws and unclear instructions are often stumbling blocks for medical device end users. Patients and their needs must be at the forefront of the design process.
 
view
download pdf
Improving Patient Adherence

Spotlight - Dose Counting for Metered-Dose Inhalers – A Real Patient Need

Keeping track of patient adherence is tough – even for the patients themselves. A smartphone connected inhaler can help to monitor doses and report back for the benefit of patients and medical professionals, say H&T Presspart.
 
view
download pdf
Improving Patient Adherence

The Automation of Change

Non-adherence among patients is a challenging issue, and one that has been compounded during the pandemic. Automation could be the solution that saves precious time for frontline staff.
 
view
download pdf
Improving Patient Adherence

AI Told You So

PMPS talks to IBM’s Stefan Harrer to discover how AI and machine learning can help to improve clinical trial retention rates, and how it may overcome the inevitable challenges.
 
view
download pdf
Improving Patient Adherence

Medication Adherence for the Modern COVID World

People around the world have problems understanding and picking up their prescriptions. What can the industry do to engage patients and ensure medical adherence?
 
view
download pdf
Improving Patient Adherence

Connecting Home-Based Drug Delivery

Transforming the care delivered in hospitals to safer at-home environments is a challenge in the COVID-19 landscape, but what methods are currently being used to support medical adherence?
 
view
download pdf
bullet
New Methods in Pharma Manufacturing
New Methods in Pharma Manufacturing

Five Ways to De-Risk New Product Launches

How can virtual pharmaceutical operations market their new products and overcome the challenges that will inevitably create barriers for their introduction?
 
view
download pdf
New Methods in Pharma Manufacturing

Untouched by Human Hands

Robots that can test samples accurately, manufacture medical elements, and pick and pack medicine for shipping are becoming an invaluable asset for laboratories and pharmacies around the world.
 
view
download pdf
New Methods in Pharma Manufacturing

Manufacturing Multi-Unit Drug Capsule Dosage Forms with Special Applications

From two-piece capsules developed in the 19th century to the latest methods of multi-unit drug capsule dosages, find out how the pharmaceutical industry is preparing innovative capsules for the future.
 
view
download pdf
bullet
Sustainability and COVID-19
Sustainability and COVID-19

The Fight Against Plastic Pollution

As companies around the world wrangle over their plastic usage, the pharmaceutical industry faces an uphill battle to find alternatives that improve its impact on plastic pollution.
 
view
download pdf
bullet
Talent Acquisition
Talent Acquisition

The Future of the Pharma Ecosystem Post-COVID-19

Keeping the best staff and maintaining a steady stream of graduates is not easy. Discover how talent acquisition in the pharma and life science industry is being changed by the pandemic.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >>

White Papers

Pandemic respiratory vaccine clinical trials: a departure from business as usual

ICON plc

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement